A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer

被引：0
|
作者：
Carlotta Defferrari
Sara Campora
Mauro D'Amico
Arnoldo Piccardo
Ennio Biscaldi
Daniela Rosselli
Ambra Pasa
Matteo Puntoni
Alberto Gozza
Alessandra Gennari
Silvia Zanardi
Rita Lionetto
Michela Bandelloni
Andrea DeCensi
机构：
[1] E.O. Ospedali Galliera,Unit of Medical Oncology
[2] E.O. Ospedali Galliera,Nuclear Medicine
[3] E.O. Ospedali Galliera,Radiology
[4] E.O. Ospedali Galliera,Gynecology
[5] E.O. Ospedali Galliera,Scientific Direction
[6] E.O. Ospedali Galliera,Health Direction
[7] E.O. Ospedali Galliera,Pharmacy
来源：
Journal of Ovarian Research | / 5卷
关键词：
Bevacizumab; Standardize Uptake Value; Epithelial Ovarian Cancer; Diabetic Macular Edema; Weekly Paclitaxel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients
    Yang, Shih-Hung
    Guo, Jhe-Cyuan
    Hsu, Chiun
    Kuo, Sung-Hsin
    Tien, Yu-Wen
    Cheng, Ann-Lii
    Yeh, Kun-Huei
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (01) : 97 - 105
  • [22] Effects of weekly bevacizumab and pegylated liposomal doxorubicin in heavily pretreated patients with recurrent or progressed ovarian cancer
    Kikuchi, Y., Sr.
    Kouta, H.
    Kikuchi, R.
    Takano, M.
    Kita, T.
    Kudoh, K.
    Aoki, D.
    Sugiyama, T.
    Isonishi, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
    Martin, Jovana Y.
    Urban, Renata R.
    Liao, John B.
    Goff, Barbara A.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 27 (05)
  • [24] Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma
    O'Malley, DM
    Azodi, M
    Makkenchery, A
    Tangir, J
    McAlpine, J
    Kelly, M
    Schwartz, P
    Rutherford, T
    GYNECOLOGIC ONCOLOGY, 2005, 98 (02) : 242 - 248
  • [25] Immunotherapy with subcutaneous low dose interleukin-2 plus melatonin as salvage therapy of heavily chemotherapy-pretreated ovarian cancer
    Lissoni, P
    Ardizzoia, A
    Barni, S
    Tancini, G
    Muttini, MP
    ONCOLOGY REPORTS, 1996, 3 (05) : 947 - 949
  • [26] Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series
    Ma, Helen
    Cheng, Bin
    Montanari, Francesca
    Lue, Jennifer K.
    Deng, Changchun
    Marchi, Enrica
    O'Connor, Owen A.
    Sawas, Ahmed
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [27] BEVACIZUMAB PLUS METRONOMIC CYCLOPHOSPHAMIDE FOR HEAVILY PRETREATED OVARIAN CANCER: A SINGLE INSTITUTION EXPERIENCE
    Ghanem, I.
    Mendiola, C.
    Diaz, A.
    Velasco, G.
    Manso, L.
    Ciruelos, E.
    Manneh, R. A.
    Hoyos, S.
    Pascual, T.
    Cortes-Funes, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 325 - 325
  • [28] Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
    Lee, Hee Jun
    Kim, Hee Seung
    Park, Noh Hyun
    Chung, Hyun Hoon
    Kim, Jae Weon
    Song, Yong Sang
    CANCER RESEARCH AND TREATMENT, 2013, 45 (01): : 40 - 47
  • [29] TRABECTEDIN IN HEAVILY PRETREATED RECURRENT OVARIAN CANCER PATIENTS: A CASE-CONTROL STUDY
    Panici, P. Benedetti
    Marchetti, C.
    Musella, A.
    Romito, A.
    Vertechy, L.
    Lecce, F.
    Tomao, F.
    Di Donato, V.
    Perniola, G.
    Palaia, I.
    Muzii, L.
    Monti, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 638 - 638
  • [30] Low-dose nab-paclitaxel-based combination chemotherapy in heavily-pretreated pancreatic or ampullary cancer patients: Taiwanese single-center case series.
    Yang, Shih-Hung
    Guo, Jhe-Cyuan
    Hsu, Chiun
    Hsu, Chih-Hung
    Kuo, Sung Hsin
    Cheng, Ann-Lii
    Yeh, Kun-Huei
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345